Stephen P Hack
5PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 18, 2024
Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial.Teresa Macarulla, Zhenggang Ren, Hong Jae Chon
|May 22, 2023
Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework.Colby S Shemesh, Phyllis Chan, Mathilde Marchand
|Aug 30, 2021
Atezolizumab: an investigational agent for the treatment of biliary tract cancer.Stephen P Hack, Andrew X Zhu
|Aug 11, 2021
IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer.Stephen P Hack, Wendy Verret, Sohail Mulla
|May 01, 2020
IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation.Stephen P Hack, Jessica Spahn, Minshan Chen
Pageof 1
Frequent Collaborators
1 joint publications
Andrew X Zhu
1 joint publications
Colby S Shemesh
1 joint publications
Phyllis Chan
1 joint publications
Antonio Gonçalves
1 joint publications
Benjamin Wu
1 joint publications
Rene Bruno
1 joint publications
Teresa Macarulla
1 joint publications
Hong Jae Chon
1 joint publications
Joon Oh Park
1 joint publications
Tiziana Pressiani
